Welcome to Subsite of Pharmacovigilance, National Agency of Drug and Food Control Indonesia

National Agency of Drug and Food Control, Republic of Indonesia, proudly presents a specific subsite for adverse drug reaction monitoring activities and or now it is known as Pharmacovigilance. This subsite is developed to improve and strengthen pharmacovigilance system and drug safety in Indonesia.

As we know, that in line with the fast development of technology, the need of information and its access by public is also emerging, including access to drug safety  information. This sub site is designed to providing information on drug safety and pharmacovigilance activities. One of menu in this subsite is ADR Report. This menu allows healthcare professionals (HCPs) and pharmaceutical industries to submit ARDs reports to NADFC electronically. To participate in ADRs reporting using the menu of this subsite, HCPs or pharmaceutical industries shall register or subscribe first.

This reporting mechanism is an additional to established mechanisme which is paper based reporting using Yellow form. It is hope that this new reporting mechanism will facilitate HCP and pharmaceutical industry to easily participate in ADRs reporting, and furthermore it is also hope that reporting rate will increase as well.


Despite ADRs report Menu, there are other menu which are NEWS and Calendar Events. On News menu, you may access information regarding drug safety news enforced by NADFC, and in Calendar Events Menu, it is about events relating with NADFC and its acitivities on pharmacovigilance.


This is our wellcome notes for all of you, this sub site is still away from \\'perfect\\', but we will grow with your constructive suggestions and critics.



Thank you,


 


Administrator


Pharmacovigilance Team,


National Agency of Drug and Food Control


Indonesia

Poll
Menurut anda bagaimana isi dan tampilan dari website ini ?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?